Analyst
William Blair
Equibles does not estimate personal net worth.
Andrew Breckman is recorded as Analyst at William Blair. Andrew Breckman has spoken on 3 earnings calls across 3 companies, most recently for Biodesix Inc on May 4, 2026. Those appearances were for Biodesix Inc (BDSX), Tempus AI, Inc. (TEM) and QuidelOrtho Corp (QDEL). The companies whose calls Andrew Breckman spoke on are classified in the Healthcare sector.
“I wanted to focus on the commercial team. I think you caught out about 15% of volumes were coming from the primary care channel So clearly, something's working.”
“Eric, it's sort of been just over a year since you closed on AMBRI. And if we sort of go back to when that acquisition was announced, sort of a big part of that thesis was really around the data that you would be able to sort of generate across the entire sort of oncology testing spectrum.”
“Joe, I think in the assumptions you said that China is still expecting to grow mid to high single digits for the year. What sort of underpins your confidence in that growth rate?”
William Blair
Analyst
Transcript header (unverified)
BDSX
Diagnostics & Research · Healthcare
TEM
Health Information Services · Healthcare
QDEL
Medical Devices · Healthcare
